Literature DB >> 19571296

Cartilage transplantation techniques for talar cartilage lesions.

Matthew E Mitchell1, Eric Giza, Martin R Sullivan.   

Abstract

Talar articular cartilage is known to differ significantly from knee cartilage. Even so, recommendations for the treatment of talar cartilage lesions have been based on strategies for the knee. Arthroscopic management of osteochondral lesions of the talus is well documented. Results have been favorable with reparative techniques such as débridement with curettage and débridement with drilling, whether undertaken via early open techniques or more recent arthroscopic procedures. Salvage of failed reparative techniques is controversial. Early efforts to salvage failed débridement focused on osteochondral allografts and autografts that used the knee as a donor site. Results of these restorative techniques have been favorable, but concerns have been raised regarding knee donor site morbidity, the use of malleolar osteotomy, and incomplete restoration of the talar articular surface. More recent restorative techniques developed for the knee have been adapted for the ankle, such as autologous chondrocyte implantation and matrix-induced autologous chondrocyte implantation.

Entities:  

Mesh:

Year:  2009        PMID: 19571296     DOI: 10.5435/00124635-200907000-00001

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  11 in total

1.  Midterm clinical results of osteochondral autograft transplantation for advanced stage Freiberg disease.

Authors:  Wataru Miyamoto; Masato Takao; Shinya Miki; Hirotaka Kawano
Journal:  Int Orthop       Date:  2015-09-29       Impact factor: 3.075

2.  Treatment of osteochondral lesions of the talus in athletes: what is the evidence?

Authors:  Francesca Vannini; Giuseppe Gianluca Costa; Silvio Caravelli; Gherardo Pagliazzi; Massimiliano Mosca
Journal:  Joints       Date:  2016-08-18

3.  Autologous chondrocyte implantation for the treatment of chondral and osteochondral defects of the talus: a meta-analysis of available evidence.

Authors:  Philipp Niemeyer; Gian Salzmann; Hagen Schmal; Hermann Mayr; Norbert P Südkamp
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-10-30       Impact factor: 4.342

4.  Osteochondral transplantation of autologous graft for the treatment of osteochondral lesions of talus: 5- to 7-year follow-up.

Authors:  Dimitrios Georgiannos; Ilias Bisbinas; Athanasios Badekas
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-10-19       Impact factor: 4.342

Review 5.  Cartilage repair techniques of the talus: An update.

Authors:  Mike H Baums; Wolfgang Schultz; Tanja Kostuj; Hans-Michael Klinger
Journal:  World J Orthop       Date:  2014-07-18

6.  The use of fibrin matrix-mixed gel-type autologous chondrocyte implantation in the treatment for osteochondral lesions of the talus.

Authors:  Kyung Tai Lee; Jin Su Kim; Ki Won Young; Young Koo Lee; Young Uk Park; Yong Hoon Kim; Hun Ki Cho
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-06-30       Impact factor: 4.342

Review 7.  Current management of talar osteochondral lesions.

Authors:  Arianna L Gianakos; Youichi Yasui; Charles P Hannon; John G Kennedy
Journal:  World J Orthop       Date:  2017-01-18

Review 8.  No superior treatment for primary osteochondral defects of the talus.

Authors:  Jari Dahmen; Kaj T A Lambers; Mikel L Reilingh; Christiaan J A van Bergen; Sjoerd A S Stufkens; Gino M M J Kerkhoffs
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-06-27       Impact factor: 4.342

9.  Three-dimensional matrix-induced autologous chondrocytes implantation for osteochondral lesions of the talus: midterm results.

Authors:  B Magnan; E Samaila; M Bondi; E Vecchini; G M Micheloni; P Bartolozzi
Journal:  Adv Orthop       Date:  2012-04-17

10.  Management of Osteochondral Lesions of the Talar Dome.

Authors:  Chamnanni Rungprai; Joshua N Tennant; Ryan D Gentry; Phinit Phisitkul
Journal:  Open Orthop J       Date:  2017-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.